TRIP6 and colorectal adenocarcinoma: In summary, these findings collectively indicate that TRIP6 plays a critical role in promoting the malignant progression of colorectal adenocarcinoma, and its knockdown effectively suppresses tumor cell proliferation, migration, and invasion in vitro.